Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Electi… (NCT04908553) | Clinical Trial Compass
CompletedPhase 4
Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults
China650 participantsStarted 2021-07-01
Plain-language summary
Research objective: To explore the safety and dose exploration of Remimazolam Tosilate for Injection for induction and maintenance of general anesthesia in elective short-term surgery in adults.
Main research indicators:(1)Success rate of sedation during induction and maintenance of general anesthesia with remazolam tosylate;(2)The incidence and severity of hypotension in the induction and maintenance phases Study design: Multi-center, randomized, double-blind clinical study. Subject population: patients undergoing elective short-term surgery. Research data collection period: The subject signs the consent form until discharge or death in the hospital or withdrawal from the research.
Number of research centers/sample size: It is planned to enroll 600 patients from 11 hospitals.
Research process: The researchers will include patients who meet the enrollment criteria and agree to participate in the investigation of the support laryngoscope surgery and minor head and neck surgery patients from the elective surgery patients.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. ASA â… -â…¢ grade;
✓. age 18-65 years old;
✓. gender is not limited;
✓. planned elective support laryngoscope surgery (glottic polypectomy under support laryngoscope, epiglottic cyst excision under support laryngoscope, benign laryngeal under support laryngoscope Lesion resection), endoscopic septoplasty, endoscopic tympanoplasty, endoscopic middle ear tube insertion, nasopharyngoplasty, head and neck benign mass resection for general anesthesia intubation patients;
✓. operation time No more than 90min.
Exclusion criteria
✕. abnormal renal function (urea nitrogen ≥1.5×ULN, blood creatinine greater than the upper limit of normal);
✕. abnormal liver function;
✕. hypovolemia, shock or coma;
✕. suffering from mental illness and long-term use of psychotropic drugs;
What they're measuring
1
Incidence of hypotension during the anesthesia
Timeframe: during the anesthesia procedure
2
The rate of Successful sedation during the anesthesia